Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Jun;21(6):669–676. doi: 10.1111/j.1365-2125.1986.tb05232.x

The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.

K Awadzi, K K Adjepon-Yamoah, G Edwards, M L Orme, A M Breckenridge, H M Gilles
PMCID: PMC1400978  PMID: 3017392

Abstract

Twenty-one patients with moderate to heavy infections with O. volvulus were treated with 25 mg of diethylcarbamazine (DEC) citrate twice daily for 10 days. In 11 patients the urine was made alkaline with sodium bicarbonate, 2 g, administered 6 hourly for three doses daily beginning 1 day before DEC was started and continued throughout the DEC therapy. Ten patients served as controls. The mean pre-dose plasma DEC concentration during treatment and the mean plasma DEC half-life were significantly higher in bicarbonate treated patients as compared to controls. Total urinary excretion of DEC was significantly less in the bicarbonate treated group than in controls. Mean overall total reaction was higher in bicarbonate-treated patients but the difference was not significant. The bicarbonate-treated group achieved a significantly greater reduction in skin microfilarial counts than the control group as assessed 1 week after completion of therapy, but there was little difference at 1 month. Microfilarial killing was associated with microfilarial mobilisation, alteration in peripheral leucocytes and elevation in serum aminotransferases in both groups. There was no effect of DEC on the number of adult worms recovered in nodules removed at the end of the therapy. This study indicates that moderate urinary alkalinisation alters the kinetics of DEC and the therapeutic response. However the severity of clinical reaction coupled with the inadequate level of microfilarial killing achieved make it unlikely that manipulation of urinary pH will be of practical value in onchocerciasis chemotherapy.

Full text

PDF
669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Fuglsang H. Topical diethylcarbamazine in ocular onchocerciasis. Trans R Soc Trop Med Hyg. 1973;67(5):710–717. doi: 10.1016/0035-9203(73)90042-4. [DOI] [PubMed] [Google Scholar]
  2. Aviel E., David R. Topical diethylcarbamazine in ocular onchocerciasis. Isr J Med Sci. 1972 Aug-Sep;8(8):1166–1168. [PubMed] [Google Scholar]
  3. Awadzi K., Dadzie K. Y., Shulz-Key H., Haddock D. R., Gilles H. M., Aziz M. A. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Ann Trop Med Parasitol. 1985 Feb;79(1):63–78. [PubMed] [Google Scholar]
  4. Awadzi K., Orme M. L., Breckenridge A. M., Gilles H. M. The chemotherapy of onchocerciasis IX. The effect of prednisone plus cyproheptadine on the Mazzotti reaction. Ann Trop Med Parasitol. 1982 Oct;76(5):547–555. doi: 10.1080/00034983.1982.11687579. [DOI] [PubMed] [Google Scholar]
  5. Awadzi K., Orme M. L., Breckenridge A. M., Gilles H. M. The chemotherapy of onchocerciasis VII. The effect of prednisone on the Mazzotti reaction. Ann Trop Med Parasitol. 1982 Jun;76(3):331–338. doi: 10.1080/00034983.1982.11687549. [DOI] [PubMed] [Google Scholar]
  6. Awadzi K. The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides. Ann Trop Med Parasitol. 1980 Apr;74(2):189–197. doi: 10.1080/00034983.1980.11687330. [DOI] [PubMed] [Google Scholar]
  7. Ben-Sira I., Aviel E., Lazar M., Liebermann T. W., Leopold I. H. Topical hetrazan in the treatment of ocular onchocerciasis. Am J Ophthalmol. 1970 Nov;70(5):741–743. doi: 10.1016/0002-9394(70)90493-9. [DOI] [PubMed] [Google Scholar]
  8. Edwards G., Awadzi K., Breckenridge A. M., Gilles H. M., Orme M. L., Ward S. A. Diethylcarbamazine disposition in patients with onchocerciasis. Clin Pharmacol Ther. 1981 Oct;30(4):551–557. doi: 10.1038/clpt.1981.202. [DOI] [PubMed] [Google Scholar]
  9. Edwards G., Breckenridge A. M., Adjepon-Yamoah K. K., Orme M. L., Ward S. A. The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine. Br J Clin Pharmacol. 1981 Dec;12(6):807–812. doi: 10.1111/j.1365-2125.1981.tb01311.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Francis H., Awadzi K., Ottesen E. A. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. Am J Trop Med Hyg. 1985 May;34(3):529–536. doi: 10.4269/ajtmh.1985.34.529. [DOI] [PubMed] [Google Scholar]
  11. Jones B. R., Anderson J., Fuglsang H. Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery. Br J Ophthalmol. 1978 Jul;62(7):428–439. doi: 10.1136/bjo.62.7.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Langham M. E., Traub Z. D., Richardson R. A transepidermal chemotherapy of onchocerciasis. Tropenmed Parasitol. 1978 Jun;29(2):156–162. [PubMed] [Google Scholar]
  13. Lazar M., Lieberman T. W., Leopold I. H. Topical diethylcarbamazine in the treatment of ocular onchocerciasis. Am J Trop Med Hyg. 1970 Mar;19(2):232–233. doi: 10.4269/ajtmh.1970.19.232. [DOI] [PubMed] [Google Scholar]
  14. Prod'hon J., Moreau J. P., Mongin C. Chimiothérapie de l'onchocercose. I. Essais de traitement de masse par la diéthylcarbamazine, le lévamisole et l'association diéthylcarbamazine + lévamisole. Med Trop (Mars) 1979 Nov-Dec;39(6):619–628. [PubMed] [Google Scholar]
  15. Rée G. H., Hall A. P., Hutchinson D. B., Weatherley B. C. Plasma levels of diethylcarbamazine in man. Trans R Soc Trop Med Hyg. 1977;71(6):542–543. doi: 10.1016/0035-9203(77)90151-1. [DOI] [PubMed] [Google Scholar]
  16. Sowa J., Sowa S. C. Long-term treatment of onchocerciasis in children with low doses of diethylcarbamazine. Ann Trop Med Parasitol. 1978 Feb;72(1):79–85. doi: 10.1080/00034983.1978.11719282. [DOI] [PubMed] [Google Scholar]
  17. Taylor H. R., Greene B. M. Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis. Br J Ophthalmol. 1981 Jul;65(7):494–502. doi: 10.1136/bjo.65.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Taylor H. R., Langham M. E., de Stahl E. M., Figueroa L. N., Beltranena F. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala. Tropenmed Parasitol. 1980 Sep;31(3):357–364. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES